Neil O'Neill Gilmore, CEO at Editas Medicine, Inc. (EDIT), sold 5,603 shares at $2.15 ($12K) on 2025-12-03, disclosed to the SEC on 2025-12-04.
Open-market sale of $12k EDIT by CEO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| EDIT | SELL | 2026-03-04 | $11K | — | Filing → |
| EDIT | SELL | 2025-09-04 | $15K | — | Filing → |
| EDIT | SELL | 2025-06-04 | $26K | — | Filing → |